ReviewLancet regional health. Americas2025
Ensuring respiratory protection to improve population health, economic vitality, and national security.
Review in Lancet regional health. Americas, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Respiratory protection decreases the risk of inhalation-related illnesses, but only if such protection is available, with a robust framework in place to support it. There are many current and potential inhalational hazards, and without adequate respiratory protection, these threaten not only health, but also economic prosperity and national security. The United States needs to build off existing expertise to implement a framework for respiratory protection of the entire populace. A recent National Academies of Sciences, Engineering and Medicine Report laid out detailed recommendations for such a framework, and there are steps that can be taken now. Starting such a framework in the most cost-effective and efficient way possible requires preserving the existing expertise, experience, and infrastructure in NIOSH (National Institute for Occupational Safety and Health) and the National Personal Protective Technologies Laboratory.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.